ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation31This document was approved by the American College of Cardiology Board of Trustees in August 2001, the American Heart Association Science Advisory and Coordinating Committee in August 2001, and the European Society of Cardiology Board and Committee for Practice Guidelines and Policy Conferences in August 2001.32When citing this document, the American College of Cardiology, the American Heart Association, and the European Society of Cardiology would appreciate the following citation format: Fuster V, Rydén LE, Asinger RW, Cannom DS, Crijns HJ, Frye RL, Halperin JL, Kay GN, Klein WW, Lévy S, McNamara RL, Prystowsky EN, Wann LS, Wyse DG. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation). J Am Coll Cardiol 2001;38:XX-XX.33This document is available on the World Wide Web sites of the American College of Cardiology (www.acc.org), the American Heart Association (www.americanheart.org), the European Society of Cardiology (www.escardio.org), and the North American Society of Pacing and Electrophysiology (www.naspe.org). Single reprints of this document (the complete Guidelines) to be published in the mid-October issue of the European Heart Journal are available by calling +44.207.424.4200 or +44.207.424.4389, faxing +44.207.424.4433, or writing Harcourt Publishers Ltd, European Heart Journal, ESC Guidelines – Reprints, 32 Jamestown Road, London, NW1 7BY, United Kingdom. Single reprints of the shorter version (Executive Summary and Summary of Recommendations) published in the October issue of the Journal of the American College of Cardiology and the October issue of Circulation, are available for $5.00 each by calling 800-253-4636 (US only) or by writing the Resource Center, American College of Cardiology, 9111 Old Georgetown Road, Bethesda, Maryland 20814. To purchase bulk reprints specify version and reprint number (Executive Summary 71-0208; full text 71-0209) up to 999 copies, call 800-611-6083 (US only) or fax 413-665-2671; 1000 or more copies, call 214-706-1466, fax 214-691-6342; or E-mail: [email protected].
Valentı́n Fuster(Mount Sinai Hospital), Adam Torbicki(European Hospital), Samuel Lévy(Aix-Marseille Université), Elliott M. Antman(Brigham and Women's Hospital), Raymond J. Gibbons(Mayo Clinic), Carina Blomström‐Lundqvist(Örebro University), Alice K. Jacobs(Boston Medical Center), Lars Rydén(Karolinska Institutet), Richard O. Russell, Marcus Flather(Norfolk and Norwich University Hospital), Robert L. McNamara, Ángeles Alonso-García(European Society of Cardiology), David S. Cannom, G. Neal Kay(University of Alabama at Birmingham), Richard Asinger(Hennepin Healthcare Research Institute), J Hradec(Apple (Israel)), Guy De Backer(Ghent University), L. Samüel Wann, Loren F. Hiratzka(Bethesda North Hospital), Sidney C. Smith(University of North Carolina at Chapel Hill), Robert L. Frye(Mayo Clinic in Arizona), Jonathan L. Halperin(Icahn School of Medicine at Mount Sinai), Harry J.G.M. Crijns(University Medical Center), Werner Klein(European Society of Cardiology), Sigmund Silber(Praxis für Humangenetik), Ali Oto, Joseph S. Alpert(University of Arizona), David P. Faxon(Memorial Hermann), D. George Wyse(Libin Cardiovascular Institute of Alberta), Eric N. Prystowsky(St. Vincent Hospital), Gabriel Gregoratos, Alexander Parkhomenko
Cited by 47
Related Papers
The Sequence of the Human Genome
|Science|2001|13.7k
2018 ESC/ESH Guidelines for the management of arterial hypertension
|European Heart Journal|2018|10.5k
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
|New England Journal of Medicine|2011|9.4k
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k